Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful. (Q43816514)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 February 2012

Language	Label	Description	Also known as
English	Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful.	scientific article published on 9 February 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Javier Ballesteros

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Giovanna Roncador

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Africa Garcia.Orad

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Maialen Martin-Arruti

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Manuel Vaquero

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ramón Díaz de Otazu

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Iñaki Zabalza

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

9 February 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

60

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

785-792

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Diffuse large B-cell lymphomas and burkitt lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Diffuse aggressive B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Prognostic evaluation of immunohistochemical profiles in diffuse large B-cell lymphoma: a Chinese study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Prognostic evaluation of nodal diffuse large B cell lymphoma by immunohistochemical profiles with emphasis on CD138 expression as a poor prognostic factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Clinical relevance of CD10, BCL-6 and multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04160.X

21 January 2018

Identifiers

10.1111/J.1365-2559.2011.04160.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321048%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43816514&oldid=2103602387"